Cellosaurus KOLF2.1J RAB39B T168K REV/Y (CVCL_E5EE)
| Cell line name | KOLF2.1J RAB39B T168K REV/Y |
|---|---|
| Synonyms | JIPSC001334 |
| Accession | CVCL_E5EE |
| Resource Identification Initiative | To cite this cell line use: KOLF2.1J RAB39B T168K REV/Y (RRID:CVCL_E5EE) |
| Comments | From: The Jackson Laboratory; Bar Harbor; USA. Population: Caucasian; British. Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the hemizygously edited RAB39B p.Thr168Lys (c.503C>A) cell line (JAX=JIPSC001334). Derived from site: In situ; Skin; UBERON=UBERON_0002097. Cell type: Fibroblast of skin; CL=CL_0002620. |
| Sequence variations |
|
| Disease | Waisman syndrome (NCIt: C184991) Early-onset parkinsonism-intellectual disability syndrome (ORDO: Orphanet_2379) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_E5EF (KOLF2.1J RAB39B T168K SNV/Y) |
| Sex of cell | Male |
| Age at sampling | 55-59Y |
| Category | Induced pluripotent stem cell |
| Web pages | Provider; JAX; JIPSC001334; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001334 |
| Entry history | |
| Entry creation | 19-Dec-2024 |
| Last entry update | 10-Apr-2025 |
| Version number | 2 |